Home Overview Press Room Blog Publications For Students about us
Search

Personal genomics : Displaying 21-40 of 533


Hacking Your DNAby David Ewing DuncanNewsweekMarch 12th, 2014Imagine a future when Big Data has access not only to your shopping habits, but also to your DNA and other deeply personal data collected about our bodies and behavior. What will the government and others do with that data?
In Me We Trust: Public Health, Personalized Medicine, and the Common Goodby Donna DickensonThe Hedgehog ReviewMarch 12th, 2014We should not underestimate the strength of the commercial and biotechnological interests supporting Me Medicine. We need to reclaim biotechnology for the general good and break down the enclosures that threaten to circumscribe the genetic commons.
FDA Halts 23andMe Personal Genetic Testsby Marcy Darnovsky and Jessica CussinsMedical Laboratory ObserverMarch 10th, 2014After a series of setbacks, what will the future hold for direct-to-consumer genetic testing?
Human Longevity, Inc.by Pete ShanksBiopolitical TimesMarch 6th, 2014Craig Venter's new genomics company may face some stiff competition.
China Cracks Down on DNA Testingby Shu-Ching Jean ChenForbesMarch 3rd, 2014Early in February, the Chinese government quietly put the brakes on the provision of genetic tests to customers by domestic hospitals and a variety of medical and health institutions.
The Dilemma of Whether to Release Genetic Informationby Xavier SymonsBioEdgeMarch 1st, 2014New studies are suggesting that doctors need to be more cautious when they release genetic information to patients.
The Market For DNA Sequencing-Based Down Syndrome Tests Could Exceed $6 Billionby Matthew HerperForbesFebruary 28th, 2014A study shows that a new DNA-sequencing based blood test provides a dramatic improvement in accuracy at screening for Down syndrome and a second, deadly disorder.
Test Is Improved Predictor of Fetal Disordersby Pam BelluckNew York TimesFebruary 26th, 2014A test that analyzes fetal DNA found in a pregnant woman’s blood proved much more accurate in screening for Down syndrome and another chromosomal disorder than the now-standard blood test, a new study has found.
Is Genetic Testing Humans Playing God?by Robert KlitzmanCNNFebruary 22nd, 2014Pre-implantation genetic diagnosis allows doctors to test embryos before they are implanted into a woman's womb, to help ensure that certain gene mutations are not passed on. But this procedure is raising myriad complex ethical and social issues.
Old Songs, New Tests, and Expensive Childrenby George Estreich, Biopolitical Times guest contributorFebruary 20th, 2014The CEO of AOL justified a restructuring of the company’s 401(K) plan by citing two "distressed babies." This tone-deaf insensitivity was answered by a disapproving choir, but it sadly resembles too many descriptions of the "cost" of people with disabilities.
Love is in The Air Your Genesby Jessica CussinsBiopolitical TimesFebruary 14th, 2014Missing that je ne sais quoi with someone new this Valentine’s Day? A Canada-based startup claims to have mastered the science behind that illusive chemistry.
'There is no DNA Test to Prove You're Native American'by Linda GeddesNew ScientistFebruary 13th, 2014DNA testing is changing how Native Americans think about tribal membership. Yet anthropologist Kim Tallbear warns that genetic tests are a blunt tool, and tribal identity not just a matter of blood ties.
Why Family Caregivers Should Care for their Families' Genetic Inheritance Data[With CGS's Marcy Darnovsky]by Dr. Gordon AtherleyVoice AmericaFebruary 10th, 2014Marcy Darnovsky and Jeff Nisker discuss the benefits and risks associated with the use of families’ genetic inheritance data for research and for medical treatment.
Whole Genome Testing Used to Guide Breast Cancer Treatmentby Barbara CzubBioNewsFebruary 10th, 2014Whole genome testing has been used to guide tailored treatment against advanced breast cancer in a group of 43 patients.
The Path to Reading a Newborn’s DNA Mapby Anne EisenbergThe New York TimesFebruary 8th, 2014What if laboratories could run comprehensive DNA tests on infants at birth? Should parents be told of each variation, even if any risk is still unclear? Would they even want to know?
Myriad Settles Gene Patent Lawsuit Against Texas Firmby Tom HarveyThe Salt Lake TribuneFebruary 7th, 2014Myriad Genetics has reached a settlement with Gene by Gene Ltd. and vows to continue legal battles against other competitors trying to jump into the market.
Uzbekistan Is Using Genetic Testing to Find Future Olympiansby Ron Synovitz and Zamira EshanovaThe AtlanticFebruary 6th, 2014The idea of using genetic testing to spot future world-class athletes has been bandied about for years. Uzbekistan is now testing children as young as 10 to determine their athletic potential.
The $1,000 Genome: Game Changer or PR Stunt?by Jessica CussinsBiopolitical TimesFebruary 6th, 2014The DNA sequencing company Illumina announced a new product capable of sequencing an entire human genome for under $1,000. What are the hidden costs? What are the implications of reaching this long-awaited benchmark?
Genetics for the People?by Donna DickensonProject SyndicateFebruary 5th, 2014The rhetoric of personal ownership and control touted by 23andMe hides their flimsy data and actual business plan.
Ethics Questions Arise as Genetic Testing of Embryos Increasesby Gina KolataThe New York TimesFebruary 3rd, 2014The procedure raises unsettling ethical questions that trouble advocates for the disabled and have left some doctors struggling with what they should tell their patients.
Displaying 21-40 of 533  
< Prev  Next >> 
« First Page Last Page » 
« Show Complete List » 


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1936 University Ave, Suite 350, Berkeley, CA 94704 • • (p) 1.510.665.7760 • (F) 1.510.665.8760